BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1334011)

  • 21. Clinical implications of alpha-fetoprotein in chronic hepatitis C.
    Tai WC; Hu TH; Wang JH; Hung CH; Lu SN; Changchien CS; Lee CM
    J Formos Med Assoc; 2009 Mar; 108(3):210-8. PubMed ID: 19293036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
    Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
    Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galactose loading tests in patients with hepatocellular carcinoma for the assessment of chemotherapy.
    Buzzelli G; Meacci E; Smorlesi C; Chiarantini E; Birardi A; Gentilini P
    Chemioterapia; 1987 Aug; 6(4):306-9. PubMed ID: 2820595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
    Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinomas do not compromise quantitative tests of liver function.
    Ganslmayer M; Ocker M; Zopf S; Schuppan D; Hahn EG; Herold C
    Hepatogastroenterology; 2005; 52(63):881-4. PubMed ID: 15966225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
    Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
    Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of quantitative liver function tests--caffeine clearance and galactose elimination capacity--after orthotopic liver transplantation.
    Nagel RA; Dirix LY; Hayllar KM; Preisig R; Tredger JM; Williams R
    J Hepatol; 1990 Mar; 10(2):149-57. PubMed ID: 2332584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.
    Koeda N; Iwai M; Kato A; Suzuki K
    Aliment Pharmacol Ther; 2005 Apr; 21(7):851-9. PubMed ID: 15801920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels.
    Ito T; Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S
    J Viral Hepat; 2015 Oct; 22(10):777-83. PubMed ID: 25608086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato.
    Salerno F; Borroni G; Moser P; Sangiovanni A; Almasio P; Budillon G; Capuano G; Muraca M; Marchesini G; Bernardi M; Marenco G; Molino G; Rossaro L; Solinas A; Ascione A
    J Hepatol; 1996 Oct; 25(4):474-80. PubMed ID: 8912146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial quantitative liver function tests in patients with primary biliary cirrhosis: a prospective long-term study.
    v Schönfeld J; Breuer N; Zotz RB; Beste M; Goebell H
    Digestion; 1997; 58(4):396-401. PubMed ID: 9324169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
    Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term and short-term effects of hemodialysis on liver function evaluated using the galactose single-point test.
    Hou YC; Liu WC; Liao MT; Lu KC; Lo L; Pan HC; Wu CC; Hu OY; Tang HS
    ScientificWorldJournal; 2014; 2014():260939. PubMed ID: 25121113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liver function tests in a clinical comparison].
    Stremmel W; Wojdat R; Groteguth R; Zoedler M; Ebener T; Niederau C; Becker H; Strohmeyer G
    Z Gastroenterol; 1992 Nov; 30(11):784-90. PubMed ID: 1471385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Kim EJ; Yeon JE; Kwon OS; Lee HN; Shin SK; Kang SH; Byun KS; Kim JH; Kwon SY; Suh SJ; Yim HJ; Kim YS; Kim JH
    Dig Dis Sci; 2017 Mar; 62(3):808-816. PubMed ID: 28035553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.